Published in Pain on April 18, 2017
Placebo analgesia: psychological and neurobiological mechanisms. Pain (2013) 2.65
Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron (2009) 2.55
The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov (2013) 2.00
Direct evidence for spinal cord involvement in placebo analgesia. Science (2009) 1.82
The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus. Nat Med (2012) 1.72
Anterior insula integrates information about salience into perceptual decisions about pain. J Neurosci (2010) 1.72
KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. Proc Natl Acad Sci U S A (2010) 1.64
Prestimulus functional connectivity determines pain perception in humans. Proc Natl Acad Sci U S A (2009) 1.61
Decoding the perception of pain from fMRI using multivariate pattern analysis. Neuroimage (2012) 1.28
The salt-wasting phenotype of EAST syndrome, a disease with multifaceted symptoms linked to the KCNJ10 K+ channel. Pflugers Arch (2011) 1.23
The placebo effect: advances from different methodological approaches. J Neurosci (2011) 1.13
Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli. Gastroenterology (2010) 1.12
Attention modulates spinal cord responses to pain. Curr Biol (2012) 1.11
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5. J Biol Chem (2009) 1.06
White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain (2012) 1.06
Treating pain with pain: supraspinal mechanisms of endogenous analgesia elicited by heterotopic noxious conditioning stimulation. Pain (2010) 1.05
Nonmotor symptoms in genetic Parkinson disease. Arch Neurol (2010) 1.03
Flexible cerebral connectivity patterns subserve contextual modulations of pain. Cereb Cortex (2010) 1.01
Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts. Am J Physiol Heart Circ Physiol (2010) 1.00
Galectin-1 expression in human glioma cells: modulation by ionizing radiation and effects on tumor cell proliferation and migration. Oncol Rep (2007) 0.97
Blockade of endogenous opioid neurotransmission enhances acquisition of conditioned fear in humans. J Neurosci (2008) 0.95
Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain (2011) 0.94
Ventral striatal activity correlates with memory confidence for old- and new-responses in a difficult recognition test. PLoS One (2013) 0.92
Amygdala activity contributes to the dissociative effect of cannabis on pain perception. Pain (2013) 0.92
Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's disease. J Neurosci (2014) 0.92
Event-related nociceptive arousal enhances memory consolidation for neutral scenes. J Neurosci (2012) 0.91
Perceived pain, fear of falling and physical function in women with osteoporosis. Gait Posture (2010) 0.91
Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration. Mov Disord (2015) 0.91
Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes. Neurobiol Aging (2006) 0.89
Role of functional imaging in neurological disorders. J Magn Reson Imaging (2006) 0.87
Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach. Mov Disord (2009) 0.87
Effect of oxytocin on placebo analgesia: a randomized study. JAMA (2013) 0.87
Neural response to emotional stimuli during experimental human endotoxemia. Hum Brain Mapp (2012) 0.87
Depression and quality of life in monogenic compared to idiopathic, early-onset Parkinson's disease. Mov Disord (2012) 0.86
Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10. Eur Neurol (2003) 0.86
The effect of opioid receptor blockade on the neural processing of thermal stimuli. PLoS One (2010) 0.86
Differential neurophysiological correlates of bottom-up and top-down modulations of pain. Pain (2015) 0.86
Initial experience with ropinirole PR (prolonged release). J Neurol (2008) 0.86
MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease. Mov Disord (2006) 0.85
The effect of treatment history on therapeutic outcome: an experimental approach. JAMA Intern Med (2013) 0.85
Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease. Brain (2013) 0.84
Pain-specific modulation of hippocampal activity and functional connectivity during visual encoding. J Neurosci (2013) 0.83
Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease. Mov Disord (2010) 0.81
Age-dependent decline of endogenous pain control: exploring the effect of expectation and depression. PLoS One (2013) 0.80
Pylorus preserving loop duodeno-enterostomy with sleeve gastrectomy - preliminary results. BMC Surg (2014) 0.80
Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease. Neurobiol Dis (2002) 0.79
Angiotensin converting enzyme has an inhibitory role in CGRP metabolism in human skin. Peptides (2006) 0.79
Waking up the brain: a case study of stimulation-induced wakeful unawareness during anaesthesia. Prog Brain Res (2009) 0.79
Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease. Mov Disord (2009) 0.78
STN stimulation in general anaesthesia: evidence beyond 'evidence-based medicine'. Acta Neurochir Suppl (2013) 0.78
Imaging movement-related activity in medicated Parkin-associated and sporadic Parkinson's disease. Parkinsonism Relat Disord (2010) 0.78
Representation of spatial information in key areas of the descending pain modulatory system. J Neurosci (2014) 0.78
Severe glycerol intoxication after Menière's disease diagnostic--case report and overview of kinetic data. Clin Toxicol (Phila) (2009) 0.76
Response to the letter to the editor by L.A. Avila. Pain (2013) 0.75
Greater fear of visceral pain contributes to differences between visceral and somatic pain in healthy women. Pain (2017) 0.75
Altered neural responses to heat pain in drug-naive patients with Parkinson disease. Pain (2017) 0.75
[Placebo analgesia]. MMW Fortschr Med (2014) 0.75
Combined glutamate and glutamine levels in pain-processing brain regions are associated with individual pain sensitivity. Pain (2016) 0.75
Reinstatement of pain-related brain activation during the recognition of neutral images previously paired with nociceptive stimuli. Pain (2015) 0.75